Moshe Oren
Affiliations: | MCB Molecular Cell Biology | Weizmann Institute of Science, Rehovot, Israel |
Area:
Molecular BiologyGoogle:
"Moshe Oren"Children
Sign in to add trainee| Ayelet Shmueli | grad student | 2007 | Weizmann Institute |
| Yaara Ofir-Rosenfeld | grad student | 2009 | Weizmann Institute |
| Efrat L. Lidor Nili | grad student | 2010 | Weizmann Institute |
| Neta Moskovits | grad student | 2010 | Weizmann Institute |
| Efrat L. Nili | grad student | 2010 | Weizmann Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hassin O, Sernik M, Seligman A, et al. (2023) p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells. Proceedings of the National Academy of Sciences of the United States of America. 120: e2311460120 |
| Hassin O, Oren M. (2022) Drugging p53 in cancer: one protein, many targets. Nature Reviews. Drug Discovery |
| Mukherjee S, Maddalena M, Lü Y, et al. (2022) Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins. Proceedings of the National Academy of Sciences of the United States of America. 119: e2119644119 |
| Maddalena M, Mallel G, Nataraj NB, et al. (2021) missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Shaked MS, Dassa B, Sinha S, et al. (2020) A division of labor between YAP and TAZ in non-small cell lung cancer. Cancer Research |
| Kadosh E, Snir-Alkalay I, Venkatachalam A, et al. (2020) The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. Nature |
| Benor G, Fuks G, Chin SF, et al. (2020) Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features. Molecular Oncology |
| Furth N, Pateras I, Rotkopf R, et al. (2020) Abstract IA20: LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state Molecular Cancer Research. 18 |
| Shreberk-Shaked M, Dassa B, Agostino SD, et al. (2020) Abstract B43: Division of labor between YAP and TAZ in lung cancer Molecular Cancer Research. 18 |
| Oren M. (2019) p53: not just a tumor suppressor. Journal of Molecular Cell Biology |